A week-by-week breakdown of side effects, appetite changes, weight loss, injection techniques, and what's normal versus concerning.
Starting a GLP-1 medication is not a spontaneous decision—it's a medically supervised journey. Before your first injection, your provider will have reviewed your medical history, confirmed your eligibility, and discussed realistic expectations. This conversation matters because GLP-1 medications are not weight loss magic. They are tools that work by altering your hunger signals and slowing how quickly your stomach empties food. The medication does its job; your job is to eat strategically, stay hydrated, and communicate with your healthcare team about your experience.
The first month is less about dramatic transformation and more about your body becoming acquainted with the drug. You'll be on a low starting dose—typically 0.25mg of semaglutide (found in Ozempic or Wegovy) or 2.5mg of tirzepatide (found in Mounjaro or Zepbound). This low dose is intentional. It allows your body to adjust before doses escalate, reducing the intensity of side effects and letting you establish baseline patterns around food, hydration, and energy.
Most people receive their prescription and injection supplies at home or at their provider's clinic. If you're self-injecting, you'll receive instructions on proper injection technique. If you're receiving injections in-office, your first appointment will typically be scheduled within 7 days of starting.
What you're taking: Your first injection is 0.25mg semaglutide or 2.5mg tirzepatide. This is the lowest available starting dose, designed to allow your body to adapt gradually.
What to expect: The first few days may feel surprisingly normal. Many patients report little to no appetite change in the first 24–72 hours. Your injection site might feel slightly sore or tender—this is normal. Some people experience minimal discomfort; others feel a small sting similar to a regular vaccine. The injection itself takes 5–10 seconds.
Appetite changes: Appetite suppression is not automatic. The medication works in phases. In week 1, some people notice no change at all. Others report a slight reduction in portion sizes or fewer cravings for snack foods. This is not failure of the medication—it's the beginning of the process. The appetite-suppressing effects typically become more pronounced in weeks 2 and 3 as the drug accumulates in your system.
Practical guidance: Eat your normal diet in week 1. Do not restrict calories aggressively. The medication will signal satiety when it's ready; forcing yourself to eat less now can lead to nutrient deficiency and fatigue. Track how much you're actually eating—many patients are surprised to find they're consuming significantly less without consciously trying.
Rotate your injection sites to avoid lipohypertrophy (fatty tissue buildup). Use your abdomen, outer thigh, or upper arm. If your prescription is weekly, try using a different area each week. Document your sites in a notes app or calendar to stay organized as doses increase.
What changes: Week 2 is when most patients notice a shift. The medication has had a week to distribute through your system, and side effects typically emerge. Nausea is the most common complaint. You might feel queasy in the morning, after eating certain foods, or seemingly randomly throughout the day. For some, it's mild—a slight discomfort that doesn't interfere with daily activities. For others, it's pronounced enough that they eat less simply because food seems unappealing.
Appetite suppression intensifies: This is also when the appetite-suppressing effects become undeniable for most people. You may find yourself feeling satisfied after eating half the portion you would normally eat. Some patients describe the sensation as eating and suddenly feeling "done"—not painfully full, but genuinely without hunger or desire to continue eating.
Gastrointestinal changes: Beyond nausea, some people experience constipation or loose stools. GLP-1 medications slow gastric emptying—the speed at which your stomach pushes food into the small intestine. This is how they promote satiety, but it can also cause bloating, cramping, or changes in bowel habits. These typically resolve within 2–4 weeks as your digestive system adapts.
Hydration becomes critical: Many patients report decreased thirst on GLP-1 medications, even as their bodies need more water than usual (due to faster initial weight loss). Dehydration can worsen nausea and cause headaches, dizziness, and fatigue. Set phone reminders to drink water every 2–3 hours. Aim for at least 80–100 oz daily.
Managing nausea through food: Eat smaller, frequent meals instead of three large ones. Choose lean proteins, cooked vegetables, and whole grains. Avoid fatty, greasy, or spicy foods on days when you receive your injection—many patients find that heavy foods trigger nausea. Ginger tea, peppermint, or low-sugar electrolyte drinks can help settle your stomach.
Adaptation phase: By week 3, your body is acclimating to the medication. Nausea often begins to improve—not always completely, but noticeably. Some patients report that nausea peaks on injection day (or the day after) and subsides by day 4 or 5, returning the following week when they take their next dose. This pattern is common and typically normalizes once you reach a stable maintenance dose.
Energy fluctuations: Some patients report a dip in energy around this time. This can stem from eating less than your body is accustomed to, lower water intake, or the medication itself. If you feel persistently fatigued, discuss this with your provider. It may mean you need to increase protein intake or eat slightly more overall.
Sleep disruptions: A subset of patients report changes in sleep patterns—either sleeping more deeply or experiencing lighter, fragmented sleep. These changes typically resolve within weeks. If sleep disruption is severe, your provider may recommend timing your injection differently (e.g., taking it in the morning instead of evening) to see if that helps.
Early weight loss: By week 3, you'll likely notice a change on the scale. Most of this initial weight loss is water, not fat. Your reduced calorie intake leads to glycogen depletion, and glycogen holds water—so as glycogen stores deplete, water weight drops quickly. This is normal and expected. The trend is more important than the number: as long as weight is moving downward, the medication is working as intended.
Expected weight loss: According to the STEP 1 clinical trial (semaglutide), the average weight loss in the first month on the 0.25mg dose is 3–5 pounds. This varies significantly. Some patients lose more; others lose less. Tirzepatide (SURMOUNT-1 trial) shows slightly higher first-month losses, averaging 4–6 pounds. These are averages—your individual result depends on your baseline metabolism, how much you're eating, exercise, stress, sleep, and genetics.
Dose escalation conversation: By week 4, your provider will likely increase your dose. The standard escalation schedule is:
Dose escalation can temporarily reintroduce or worsen side effects. This is normal. Your body will adapt to the new dose within 1–2 weeks. If side effects become intolerable, contact your provider immediately—dose escalation timing can sometimes be adjusted.
Assessing how you feel: Month 1 is also when you and your provider assess tolerance. Important questions to answer honestly:
If you're struggling, your provider may adjust your dose escalation schedule, suggest dietary modifications, or investigate whether underlying conditions are complicating your response. This is a partnership—speaking up about challenges is essential.
Most GLP-1 medications are self-injected weekly using a pen or pre-filled syringe. The injection is subcutaneous (under the skin), not intravenous. This makes self-injection relatively straightforward, though technique matters for comfort and efficacy.
Injection sites: You can inject into your abdomen (avoiding the area 2 inches around your navel), outer thigh, or upper arm. The abdomen typically absorbs the drug most consistently, followed by the thigh. The upper arm requires assistance or flexibility to self-inject. Rotate sites—using the same spot repeatedly can cause lipohypertrophy (fatty tissue lumps that may affect absorption).
Preparing your injection: If using a pen, allow it to sit at room temperature for 15–30 minutes before injecting. Cold medication can increase discomfort. Wash your hands and choose your injection site. Wipe the site with an alcohol pad if available, though this is not absolutely required for home injections. Let the alcohol dry completely before injecting—injecting through wet alcohol stings more.
Injection technique: Hold the pen perpendicular to your skin (at a 90-degree angle) and inject steadily. Most pens deliver the full dose over 5–10 seconds. Do not withdraw immediately—hold the needle in place for 3–5 seconds after injection to allow the medication to fully deliver and prevent backflow. Withdraw at the same angle and apply gentle pressure with a small bandage or cotton ball if needed.
Timing your injection: Many patients prefer to inject in the evening or before bed. This timing can minimize nausea during waking hours and allows your body to adjust overnight. However, the medication works regardless of time of day—choose whatever fits your schedule. Consistency matters more than specific timing.
The biggest challenge in month 1 is not resisting food—it's ensuring you eat enough. An appetite suppressant can make it easy to dip below 1,200 calories daily, which is unsustainable and can trigger fatigue, nutrient deficiency, and metabolic slowdown.
Protein first: Prioritize protein in every meal or snack. Aim for 25–30g of protein per meal. This protects muscle mass, extends satiety between meals, and ensures your body has the building blocks it needs despite reduced overall intake. High-protein options that are GLP-1-friendly include chicken breast, Greek yogurt, cottage cheese, eggs, fish, legumes, and protein supplements.
Smaller, frequent meals: Instead of three meals, eat four or five smaller ones. This approach accommodates your reduced appetite while spreading nutrition throughout the day. A small meal might consist of 4 oz of grilled chicken, ½ cup of brown rice, and steamed broccoli—satisfying, nutritious, and finishable when appetite is suppressed.
Avoid fatty foods on injection days: High-fat foods take longer to digest, and when combined with slowed gastric emptying from GLP-1, they're more likely to cause discomfort and nausea. On the day of your injection and the following day, choose leaner options. By day 3 or 4 of your injection week, most people tolerate normal foods well.
Stay hydrated aggressively: Dehydration worsens nausea, causes headaches, and reduces your sense of hunger—meaning you eat even less. Drink water consistently throughout the day. If plain water feels boring, add sugar-free flavoring, herbal tea, or electrolyte supplements. Aim for at least 80–100 oz daily, more if you're exercising or in a hot climate.
Track intake loosely: You don't need to obsess over numbers, but tracking meals for a few days in month 1 helps you understand whether you're eating enough. Use an app like MyFitnessPal for 3–5 days to see your calories, protein, and micronutrient averages. Most people find they're eating 1,500–2,000 calories daily on the starting dose—which is a healthy deficit for weight loss but not dangerously low.
Mild nausea = normal. Feeling slightly queasy for a few meals or experiencing waves of nausea that come and go is expected. It typically improves within 2–4 weeks.
Appetite suppression without hunger = normal. Not feeling hungry, even after fasting, is the intended effect of the medication. This is not a sign something is wrong—it's a sign the medication is working.
Constipation or loose stools = normal. GI changes are common. Increase fiber intake gradually, drink more water, and move your body regularly. Over-the-counter remedies like docusate (Colace) are safe to use. Most patients stabilize within weeks.
Fatigue in the first 2 weeks = possibly normal. Eating less can cause fatigue. Ensure you're eating enough (aim for at least 1,200 calories daily) and consuming adequate protein. If fatigue persists beyond 2–3 weeks, contact your provider—it may indicate anemia, thyroid dysfunction, or another underlying issue.
Persistent vomiting = call your doctor. Mild nausea is expected; persistent vomiting is not. If you're unable to keep food or fluids down for more than a few hours, contact your provider immediately. You may need anti-nausea medication, a delay in dose escalation, or a dose reduction.
Severe abdominal pain = call your doctor or go to the ER. Mild cramping and bloating are normal. Sharp, severe, or persistent pain is not. This could indicate pancreatitis, bowel obstruction, or another serious condition requiring urgent evaluation.
Signs of dehydration = call your doctor. Extreme thirst, dark urine, dizziness, rapid heartbeat, or confusion indicate severe dehydration. Increase fluid intake immediately and contact your provider. You may need intravenous fluids.
Allergic reaction signs = go to the ER. Difficulty breathing, swelling of the face or throat, severe rash, or anaphylaxis require emergency care. Call 911 or go to the nearest emergency room.
GLP-1 medications are remarkably effective at reducing appetite and supporting weight loss. But they are not magic. The first month often feels miraculous—appetite drops, weight falls quickly, and many people feel hopeful about their future. This hope is justified. However, the first-month experience is not always representative of long-term results.
Initial weight loss is partly water and partly fat. As your body adjusts to the medication and as doses increase, weight loss typically slows compared to month 1. This is normal and expected, not a sign the medication has stopped working. Most patients lose 1–2 pounds per week on maintenance doses—a sustainable, healthy rate.
Additionally, medication compliance and behavioral change matter enormously. GLP-1 suppresses appetite, but it does not prevent poor food choices or mindless eating. If you're satiating quickly but eating calorie-dense or nutrient-poor foods, results will be suboptimal. The medication gives you a window of opportunity—the window where hunger isn't driving every food decision. What you do with that window determines your long-term success.
Finally, the first month is about establishing habits. Injection routines, hydration schedules, protein-first eating patterns, and regular check-ins with your provider—these become the scaffolding of your entire GLP-1 journey. Month 1 isn't the finish line; it's the foundation.
Schedule a follow-up appointment with your provider at the end of week 4. This is when dose escalation is planned, side effects are assessed, and your long-term treatment strategy is refined. Skipping check-ins can lead to missed opportunities to optimize your treatment or catch complications early.
Most people experience some side effects starting in week 2–3, with nausea being the most common. Mild nausea affecting a few meals per week is typical and usually improves as your body adapts. However, persistent vomiting, severe abdominal pain, or inability to keep food or fluids down are concerning and warrant contacting your doctor. The starting dose of 0.25mg (semaglutide) or 2.5mg (tirzepatide) is intentionally low to minimize severe side effects while allowing your body to adjust.
According to the STEP 1 clinical trial, the average weight loss on semaglutide in month 1 is 3–5 pounds, with much of this being water weight rather than fat loss. The SURMOUNT-1 trial with tirzepatide shows slightly higher first-month losses, averaging 4–6 pounds. Individual results vary significantly based on starting dose, metabolism, current weight, diet adherence, and exercise. It's important to remember that initial rapid weight loss slows as your body adapts to the medication—this is normal and expected.
Yes, absolutely. GLP-1 medications work by increasing satiety signals to your brain and slowing gastric emptying, making you feel fuller on less food. Not feeling hungry, even after fasting, is the intended effect and a sign the medication is working. However, it's important not to eat too little—aim for at least 1,200 calories daily and prioritize protein to protect muscle mass. If you find yourself unable to eat due to nausea or complete appetite loss, contact your provider about dose adjustment.
Contact your doctor if you experience persistent vomiting lasting more than a few hours, severe abdominal pain, inability to tolerate any food or fluids, signs of dehydration (extreme thirst, dark urine, dizziness, rapid heartbeat), or if you suspect an allergic reaction. You should also report any side effects you're experiencing by your week-4 check-in so your provider can assess whether dose escalation is appropriate or whether adjustments are needed. Don't wait for your scheduled appointment if you're experiencing concerning symptoms.
Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.
No spam ever. Unsubscribe anytime.
GLP1Authority.com is an independent review site. We may receive compensation when you click certain links. This does not influence our reviews or rankings. Always consult a healthcare provider before starting any medication. See our affiliate disclosure for details.
Not sure which GLP-1 program is right for you?
2 minutes. No email required.